From: The predictive value of procalcitonin for postoperative early pancreatic fistula
Characteristics | PD | POPF groups(n = 14) | non-POPF groups(n = 53) | t | X2 | P value | DP | POPF groups(n = 5) | non-POPF groups(n = 14) | t | X2 | P value |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Age (Year) | 58.64 ± 1.74 | 56.49 ± 1.69 | 0.62 | 0.53 | 53.6 ± 569 | 49.573.22 | 0.63 | 0.53 | ||||
Gender (male/female) | 10/4 | 33/20 | 0.40 | 0.52 | 1/4 | 3/11 | 0.004 | 0.94 | ||||
BMI (kg/m2) | 22.79 ± 0.84 | 23.25 ± 0.38 | 0.53 | 0.59 | 22.64 ± 0.71 | 24.65 ± 0.61 | 1.79 | 0.09 | ||||
Diabetes (n) | 3 | 6 | 0.01 | 0.90 | 0 | 2 | 0.79 | 0.37 | ||||
Previous abdominal surgery | 3 | 16 | 0.41 | 0.51 | 3 | 5 | 0.56 | 0.35 | ||||
Preoperative bilirubin (μmol/L) | 106.32 ± 0.92 | 166.9 ± 17.61 | 1.96 | 0.06 | 12.99 ± 2.89 | 8.85 ± 1.43 | 1.40 | 0.17 | ||||
Preoperative albumin(g/L) | 37.07 ± 1.79 | 40.11 ± 0.68 | 1.87 | 0.06 | 39.6 ± 0.74 | 39.86 ± 0.09 | 0.56 | 0.57 | ||||
Preoperative hemoglobin(g/L) | 122.2 ± 4.31 | 130.3 ± 2.24 | 1.64 | 0.10 | 133.1 ± 3.97 | 118.3 ± 6.64 | 1.28 | 0.21 | ||||
Operation time (min) | 242.5 ± 16.04 | 237.9 ± 7.98 | 0.26 | 0.79 | 190 ± 20.97 | 203.7 ± 14.26 | 0.50 | 0.62 | ||||
Intraoperative bleeding (ml) | 239.2 ± 25.52 | 243.5 ± 20.12 | 0.10 | 0.91 | 175.4 ± 28.23 | 134.9 ± 11.1 | 1.63 | 0.12 | ||||
Postoperative hyperglycemia (n) | 6 | 7 | 7.27 | <0.01 | 0 | 3 | 1.27 | 0.25 | ||||
Postoperative hypoproteinemia (n) | 5 | 29 | 0.00 | 0.92 | 0 | 3 | 1.27 | 0.25 | ||||
Postoperative ICU admission (n) | 6 | 10 | 6.18 | 0.01 | 4 | 1 | 10.09 | 0.001 | ||||
Tumor character (benign/malignant) | 4/10 | 6/47 | 2.59 | 0.10 | 1/4 | 7/7 | 1.36 | 0.24 | ||||
Postoperative hospital stay (d) | 34.86 ± 3.03 | 22.08 ± 1.27 | 4.37 | <0.0001 | 22.8 ± 1.42 | 16.29 ± 1.08 | 3.23 | 0.005 | ||||
Hospitalization cost (RMB ten thousand) | 11.89 ± 1.21 | 10.94 ± 0.62 | 0.69 | 0.48 | 7.34 ± 0.43 | 6.91 ± 0.50 | 0.47 | 0.64 |